Fli-1 is a proto-oncogene which is rearranged in tumors induced by three dierent retroviruses, Cas-Br-E, FMuLV, and 10A1. This gene is a member of the Ets gene family, a class of transcription factors that recognize and bind to a DNA motif known as the Ets binding site (EBS). Our laboratory has previously cloned and characterized the promoter region of both human and mouse Fli-1 genes. We had then identi®ed several regulatory elements conserved between the two species. Two of them, an exon 1 GATA/EBS dual element and an EBS element located in the 5' end of intron 1, were analysed in the present study. EMSA analysis performed with nuclear extracts from dierent cell lines showed that the EBS element in intron 1 (EBSi) was bound by one potential Ets-related ubiquitous factor. The GATA/ EBS element was bound by several factors that seemed Ets-related, one of which was found to be speci®cally expressed in hematopoietic cells. the GATA/EBS dual element was thus chosen for further analysis. A human Fli-1-derived genomic fragment containing the GATA/ EBS led to enhanced transcription when positioned upstream of the SV40 promoter in the erythroleukemic HEL cell line. In addition, an increasing number of GATA/EBS oligonucleotides upstream of this same promoter resulted in a copy number-dependent increase in luciferase activity which was greatly reduced when the EBS consensus sequence was mutated. One of the factors binding to the GATA/EBS region was identi®ed to be Spi-1 by supershift analysis and was also shown to bind to the EBS element of the human Ets-2 gene. Supershift analysis also demonstrated the binding of the GATA-1 factor to the GATA/EBS dual element. Our results suggest that Spi-1 and GATA-1 might play a key role in the regulation of Fli-1.
Introduction
Retroviruses are very useful tools to study tumor formation in several species and have enabled investigators to identify several oncogenes. The Fli-1 locus is an example of such an analysis and has been identi®ed as a common integration site for three murine retroviruses, Cas-Br-E (Bergeron et al., 1991) , Friend (Ben-David et al., 1990 and 10A1 (Ott et al., 1994) . Fine mapping of these integration events has shown that Friend MuLV is integrated upstream of the exon 1 in an inverse orientation with respect to Fli-1 transcription (Ben-David et al., 1991) while Cas-Br-E and 10A1 MuLVs were shown to integrate in the exon 1 in the same transcriptional orientation (Bergeron et al., 1992; Ott et al., 1994) . Both human and mouse Fli-1 cDNAs sequences have been reported (Ben-David et al., 1991; Prasad et al., 1992; Watson et al., 1992) and shown to code for proteins of the Ets gene family.
Members of this growing superfamily of genes are found in species such as human, mouse, cat, Drosophila, and sea urchin (for review, see Wasylyk et al., 1993) . Ets proteins are transactivators that contain at least two distinct domains: a transactivation domain, sometimes required for auto-transactivation (Schneikert et al., 1992; Siddique et al., 1993; Gauthier et al., 1993; Bhattacharya et al., 1993) , and a highly conserved DNA binding domain. The Ets Binding Domain (EBD) is responsible for the speci®city of the interaction of each member of the family with its own optimal DNA target. Nonetheless, a general core consensus sequence has been identi®ed for almost all Ets Binding Sites (EBS) and contains the sequence 5'-GGAW-3' (Wasylyk et al., 1993) .
Several genes have been shown to be regulated by Ets proteins. Although examples of repressor activity have been characterized for Ets-1, Spi-1 and ERF (Gauthier et al., 1993; Reddy et al., 1994; Goldberg et al., 1994; Sgouras et al., 1995) , most targeted genes are upregulated by speci®c Ets members. A large number of these Ets-regulated genes are linked to hematopoietic-derived cell lines but developmentallyregulated genes have also been shown to be aected in their expression by Ets proteins (for review, see Wasylyk et al., 1993; Moreau-Gachelin, 1994) . The importance of Ets proteins in vivo has been clearly exempli®ed in Spi-1 and Ets-1 gene knock-out experiments which have resulted in major impairment in hematopoiesis (Scott et al., 1994; Bories et al., 1995; Muthusamy et al., 1995) .
The expression of Fli-1 is often observed in hematopoietic-derived cell lines and in organs involved in hematopoiesis but is also found in other organs such as the heart, the brain and the lungs (Ben-David et al., 1991; Watson et al., 1992; Hromas et al., 1993a; Bergeron et al., 1993; Klemsz et al., 1993) . In human, a chromosomal translocation (11;22) found in Ewing tumors links the 3' portion of the Fli-1 gene to the 5' portion of the EWS gene yielding a fusion protein with transforming properties (Delattre et al., 1992; May et al., 1993) . The importance of Fli-1 in vivo has been demonstrated in transgenic mice, which showed renal failure and B cell superactivation following overexpression of Fli-1 . Also, gene knock out experiments in mice have suggested that Fli-1 might be important in certain steps of T-cell development (MeÂ let et al., 1996) . However, little is known with respect to the Fli-1-targeted genes. Potential implication of the Fli-1 protein in regulation of gene expression have been described for the Ig H enhancer, and the gpllb and GATA-1 promoters (Seth et al., 1993; Rivera et al., 1993; Zhang et al., 1993) . In addition, evidence in Fli-1 transgenic mice has suggested that Fli-1 could up-regulate its own expression as demonstrated by an increase in expression of the endogeneous gene in these mice .
To better understand the Fli-1 gene function(s), our laboratory has recently isolated and characterized both human and mouse Fli-1 promoters (Barbeau et al., 1996) . Our results have shown that mouse Fli-1 CAP sites are located more than 100 bp upstream of the previously described mouse 5' Fli-1 cDNA end. No or little promoter activity could be obtained with the sequence located upstream of the identi®ed mouse Fli-1 CAP sites, an observation which has been recently con®rmed by others (Prasad et al., 1998) . This is in contrast to the promoter region of a new Fli-1 exon 1 that has been identi®ed by Prasad and colleagues (1998) and has been shown to harbor a fair level of promoter activity.
Sequence analysis of the presumed promoter region of the initial exon 1 has shown high levels of homology between human and mouse sequence and demonstrated the presence of a conserved GATA/EBS dual element located in exon 1 (3' to the identi®ed CAP sites), as well as a conserved intronic EBS element near the 5' end of intron 1. Promoter and exon 1 sequences of the human Ets-1 and Ets-2, and human and mouse Spi-1 genes have also indicated the presence of EBS elements (Jorcyk et al., 1991; Mavrothalassitis et al., 1990; Chen et al., 1995) . The Ets-2 EBS element was found to be similarly oriented with respect to transcription and to share a 9 nucleotide homology in comparison to the Fli-1 EBS in exon 1. These EBS elements have been shown to be functionally important for gene regulation of Ets-1, Ets-2 and Spi-1 and in fact represent crucial elements for the autoregulatory positive loop of both Ets-1 and Spi-1 expression (Oka et al., 1991; Mavrothalassitis and Papas, 1991; MajeÂ rus et al., 1992; Chen and Wright, 1993; Chen et al., 1995) . Factors have also been shown to bind to the Ets-2 exon 1 EBS elements, only one of which has been identi®ed and termed ERF Sgouras et al., 1995) .
Since EBS elements in other Ets-related promoters have been shown to be functionally important for gene regulation, we wished to identify the proteins binding both Fli-1 EBS elements. Electrophoretic mobility shift assays (EMSA) results show that most of the retarded signals seemed dependent on the presence of an intact EBS element, although none of these signals could be related to the Fli-1 protein. One of these signals, speci®c to the GATA/EBS dual binding site, was found to be Spi-1 while another nonEts erythroid-speci®c factor was identi®ed as GATA-1. Reporter gene expression further demonstrated the capacity of this GATA/EBS region to increase transcription which was dependent on an intact EBS consensus sequence.
Results
Sequence comparison of mouse and human anking regions has shown the presence of several conserved elements including a GATA/EBS dual binding site located just 3' of the CAP sites identi®ed in the erythroleukemic CB7 cell line, and an EBS element in intron 1. The former EBS element was found to be homologous with that of the Ets-2 exon 1 over a stretch of nine nucleotides (Figure 1a) . In order to evaluate the importance of these elements in Fli-1 regulation, we have searched for factors binding speci®cally to each of these regions by EMSA using synthetic probes from both EBS-containing regions (Figure 1b ).
An Ets-related factor speci®cally binds to the Fli-1 EBS element located in intron 1 EMSA analysis was performed using the EBSi probe derived from the Fli-1 intron 1 EBS-containing region and protein extracts from hematopoietic and nonhematopoietic derived cell lines (Figure 2 ). Beside a constant non-speci®c band (NS), the double-stranded oligonucleotide EBSi generated one major speci®c band (Figure 2a ). This factor was somewhat less expressed in Figure 1 GATA and EBS elements of the Fli-1 exon and intron 1 regions and the derived oligonucleotides. (a) GATA and EBS elements, indicated by a box in the sequence, are presented with respect to human and mouse Fli-1 gene structure also in comparison to the ets-2 EBS element from the ets-2 exon 1 (Mavrothalassitis et al., 1990) . Arrows indicate the two major CAP sites (Barbeau et al., 1996) . (b) Sequence of the oligonucleotides used for EMSA. Sequences are mainly derived from mouse and human Fli-1 intron and exon 1 EBS-containing region. The GENEBANK accession numbers for mouse and human Fli-1 exon 1 regions are L47615 and L47616 respectively (Barbeau et al., 1996) . GATA and EBS elements are indicated and introduced point mutations are shown in bold letters. Sequence of the ETS-2PR oligonucleotide is derived from the human ets-2 exon 1 region (Mavrothalassitis et al., 1990) . The unrelated oligonucleotide used in this study (U) is a GATA and EBS non-containing DNA fragment K562 (Figure 2a , lane 3) but, in general, seemed fairly abundant in all other cell lines. This band was also present in nuclear extracts from cell lines CB7, M-NFS and WEHI-3B (Figure 2b ; data not shown). Several other minor bands of low molecular weight were also observed in this analysis (asterisk; see below).
To evaluate the dependence of this major binding factor for an intact EBS element, competition was carried out with wild type or mutated oligonucleotides (from 5'-GGAA-3' to 5'-GTAA-3'; see Figure 1b ). As seen in Figure 2b , a 100-fold excess of cold EBSi oligonucleotide outcompeted the major band observed with MEL, M1 and WEHI-3B nuclear extracts ( Figure  2b , lanes 5, 9 and 13). Low migrating bands seen with extract from M1 cells were also outcompeted with cold-excess oligonucleotide EBSi (Figure 2b, lane 9) . Also, competition with a 100-fold excess of the mutant oligonucleotide EBSi* or an unrelated oligonucleotide (U) did not weaken these signals (Figure 2b, lanes 6, 7, 10, 11 and 14) . In addition, the probe EBSi* could not generate any speci®c complex when incubated with MEL nuclear extracts ( Figure 2b , lane 2). Several experiments using various EBS elements have equally shown a competition for the binding of the EBS intron 1 factor (data not shown). These results suggest that the EBS element of Fli-1 intron 1 binds to a possibly ubiquitous Ets-related factor.
Multiple Ets-related factors bind speci®cally to the Fli-1 exonic GATA/EBS region EMSA analysis performed with the oligonucleotide GATA/EBS originating from the exon 1 Fli-1 sequence ( Figure 1a and b) showed a more complex band pattern. Several strong signals, including a non-speci®c band (NS), could be detected (Figure 3a ; labeled A, B, C, Q). Band C was present in erythroid (except for the CB7 cell line) and myeloid cell lines ( Figure 3a , lanes 2, 4, 8, 9 and 10) while bands A and B had a broader distribution. Band B contained two bands, one of which (Band B') was found to be the most important factor binding to the EBSi oligonucleotide (data not shown). In addition to these signals, similarly to the low molecular weight signals observed in EMSA analysis with the probe EBSi, fast migrating bands (band Q) were detected ( Figure 3a , lanes 9 and 10). These were also observed in WEHI-3B cells upon longer exposure (data not shown). The results presented in Figure 3a are summarized in Table 1 and are compared to cell type and Fli-1 expression level deduced from Northern blot experiments (data not shown). Fli-1 expression for the human cell line HEL and HL60 should not be compared to the results presented for the mouse cell line since they originate from another study (Hromas et al., 1993a) . As presented in Table 1 bands A and B seemed more ubiquitous and thus showed no direct correlation with Fli-1 expression. Band C seemed to be speci®cally present in hematopoietic-derived cell lines and was observed in most cell lines expressing Fli-1mRNA (except for the cell lines Ti6 and CB7 (Table 1) .
To analyse the requirement of the EBS element for the binding of these latter factors, EMSA analysis was performed in the presence of the competitors GATA/ EBS and oligonucleotides bearing mutations in the EBS site (GGAA to GTAA; GATA/EBS*) or in the P-labeled probes EBSi (lanes 3 ± 14) and EBSi* (lanes 1 and 2) were incubated with nuclear extracts from cell lines MEL (lanes 2, 4 ± 7), M1 (lanes 8 ± 11) and WEHI-3B (lanes 12 ± 14) or without any nuclear extracts (lanes 1 and 3). Competition was performed with oligonucleotide EBSi (Ei) (lanes 5, 9 and 13), EBSi* (Ei*) (lanes 6, 10 and 14) and an unrelated oligonucleotide (U) (lanes 7 and 11). The arrowhead indicates the major speci®c signal while a non-speci®c band is indicated as NS. The asterisk points to a minor set of speci®c bands found exclusively in myeloid cell extracts GATA site (GATA to GTTA; GATA*/EBS). As can be seen, when K562 nuclear extracts were used, GATA/EBS-speci®c bands A, B and C were outcompeted with cold-excess of GATA/EBS or GATA*/ EBS ( Figure 3b , lanes 2 and 4), while no such competition could be observed using either a 100-fold excess of GATA/EBS* or unrelated oligonucleotides ( Figure 3b , lanes 3 and 5). Furthermore using the oligonucleotide GATA/EBS* as a probe, no speci®c bands were observed upon incubation with K562 Intensity of the signals on EMSA analysis are arbitrarily evaluated and the symbol 7 indicates the absence of the signal. Comparison of the intensity was performed on the same EMSA experiment nuclear extracts (data not shown). Similar results were obtained when nuclear extracts from the MEL cell line were instead incubated in the presence of the GATA/ EBS or the GATA*/EBS probes. These results thus suggest that most of the identi®ed shift bands speci®c to the GATA/EBS Fli-1 region are representative of Ets-related factors while none seem to be GATArelated factors with the probe used. Most of them seem ubiquitous except band C which is speci®c to hematopoietic-derived cell lines.
GATA/EBS enhances transcription mediated by the SV40 promoter
Since the GATA/EBS oligonucleotide was the only EBS-containing oligonucleotide which was bound by a hematopoietic-speci®c nuclear protein, we decided to then focus on this region for further studies. We ®rst used a fragment from the human Fli-1 gene containing the conserved GATA/EBS region. This 125 bp fragment was cloned upstream of the SV40 promoter which derived the expression of a luciferase reporter gene. When either pGL3promoter SH7-S (sense) or pGL3promoter SH7-AS (antisense) constructs were introduced in the human HEL cell line, irrespective of orientation, luciferase activity after b-galactosidase normalization showed a twofold activation in comparison to cells transfected with the original pGL3promoter (Figure 4a ). However, the fragment itself when positioned into the promoterless vector pGL3basic did not give rise to any promoter activity (data not shown), thereby suggesting that the observed increase in luciferase activity in the SH7-containing pGL3 promoter constructs was truly an enhancer eect. The wild type oligonucleotide 5' GATA/EBS was then inserted in the pGL3promoter construct and generated plasmid constructs containing one, two or four copies of the dual element (pGL3promoter GATA/EBS(1), pGL3promoter GATA/EBS(2), and pGL3promoter GATA/EBS(4), respectively). When compared to pGL3 promoter-transfected cells, a copy number-dependent increase in luciferase activity was clearly apparent which augmented by 1.97-, 3.41-, and 4.42-fold with one, two and four inserted copies, respectively (Figure 4b ). The transcriptional activation achieved with one copy of the 5' GATA/EBS oligonucleotide was in fact similar to that obtained with the SH7-derived 125 bp exon 1 fragment (i.e. twofold). Furthermore, when an EBS-mutated version of the 5' GATA/EBS oligonucleotide was inserted Figure 4 GATA/EBS enhances transcription from the SV40 promoter. (a) HEL cells were co-transfected with 1 mg of pRSVb-gal and 5 mg of either pGL3promoter, pGL3promoter (SH7-S) or pGL3promoter (SH7-AS). In (b), HEL cells were similarly cotransfected with 1 mg of pRSVb-gal but with 5 mg of either pGL3promoter, pGL3promoter GATA/EBS(1), pGL3promoter GATA/ EBS(2), pGL3promoter GATA/EBS(4), or pGL3promoter GATA/EBS*(1). Luciferase activity was normalized with the measured b-galactosidase activity, and compared to that of the pGL3promoter plasmid. Results are expressed as fold induction over pGL3promoter activity. Mean value and standard deviation of triplicate samples are shown (pGL3promoter GATA/EBS*(1)), transcriptional activation was greatly reduced. These results thus suggest that the GATA/EBS region of the Fli-1 gene could act as an enhancer and be dependent on the EBS consensus sequence.
GATA-1 binds to the Fli-1 exon 1 GATA/EBS dual element
Although most bands observed in EMSA seemed to depend on an intact EBS consensus sequence, we were surprised to see that no GATA-related factors were binding to the GATA/EBS probe (see Figure 3b) . We thus presumed that the short 5' end neighboring the GATA element of this oligonucleotide could explain such results. An oligonucleotide with a longer 5' end was thus synthesized and used for EMSA analysis (5' GATA/EBS). As shown in Figure 5a , a new factor interacting with this new probe in an erythroid-speci®c fashion was seen (Figure 5a , lanes 2 ± 4). To determine whether this factor was GATA-1, supershift assay was carried out with anti-GATA-1 polyclonal antibodies. As seen in Figure 5b , using CB7 nuclear extracts, this new band was supershifted with the addition of anti-GATA-1 antibodies ( Figure 5b , lane 2) while no supershift could be seen with anti-Fli-1 polyclonal antibodies or pre-immune serum (Figure 5b, lanes 3  and 4) . Similar results on the erythroid-speci®c factor were obtained with supershift assay using nuclear extract from the D1B cell line (data not shown).
These results thus show that the GATA-1 factor interacts with the GATA/EBS region of Fli-1 exon 1.
Spi-1 is band C and also binds to the Ets-2 EBS element
One of the most interesting factors interacting with the GATA/EBS region located near the mouse Fli-1 CAP sites is the factor corresponding to band C since it is present only in hematopoietic-derived cell lines. Because of its cell line distribution (see Table 1 ) and its binding site (5'-GAGGAA-3'), we suspected that band C could be Spi-1. Supershift assays were performed in the presence of D1B and K562 nuclear extracts along with the GATA/EBS probe ( Figure 6 ). The appearance of band C was blocked with both nuclear extracts upon addition of anti-Spi-1 antibody speci®c for the amino end (Figure 6a , lanes 3 and 6) with a supershift consistently seen only with K562 nuclear extracts (Figure 6a, lane 6) . Speci®city of the binding was also con®rmed by competition with cold GATA/EBS oligonucleotide ( Figure 6a , lanes 2 and 5). In addition, EMSA performed with an oligonucleotide containing the Spi-1 binding site from the MHC class II promoter region in the presence of D1B nuclear extracts gave a single band comigrating with band C (Figure 6b ). These results thus strongly suggest that band C is Spi-1.
Because of the resemblance between the EBS elements in the Ets-2 exon 1 and Fli-1 GATA/EBS (see Figure 1a) , we next looked at the possible binding of Spi-1 to the Ets-2 EBS region. When the oligonucleotide corresponding to this site was used as a probe, a similar band (to band C) could be seen with nuclear extracts from D1B and K562 cell lines, which was weakened by the addition of amino or carboxylspeci®c anti-Spi-1 antibodies (Figure 6c, lanes 2, 5 and  6 ). This suggests that Spi-1 also interacts with the EBS element present in the Ets-2 exon 1 region and could therefore represent the previously described hematopoietic-speci®c H3 factor which was found to bind speci®cally to this EBS element . In our analysis, no supershifts speci®c to anti-Ets-2 antibodies could be obtained upon challenge of the DNA-protein complexes with the Ets-2 EBS probe (Figure 6c, lanes 3 and 7) . Similarly, no supershift could be obtained with these same antibodies when EMSA analysis was performed in the presence of the GATA/EBS probe with various cell extracts (data not shown).
EMSA analysis with the Ets-2 promoter EBS element gave similar low molecular weight bands showing myeloid speci®city which migrated with the same pattern as those described above with probes GATA/EBS and EBSi. When the Ets-2 EBS probe was incubated with M1 nuclear extracts, these low molecular weight signals were blocked with anti-Spi-1 (carboxyl end) antibodies while only the upper low molecular weight signals could be blocked by anti-Spi-1 (amino end) antibodies (data not shown). These could thus be Spi-1-related degraded products which have been previously reported in analysis of EBS elements with myeloid-derived cell lines (Pongubala et al., 1992; Carvalho and Derse, 1993a; Feinman et al., 1994; Eichbaum et al., 1994) .
Discussion
Members of the Ets family Ets-1, Ets-2 and Spi-1 all contain EBS elements at their 5' end (Mavrothalassitis et al., 1990; Jorcyk et al., 1991; Chen et al., 1995) . These elements have been shown to be important in gene regulation as mutation or deletion of these elements greatly aected promoter strength (Chen and Wright, 1993; Mavrothalassitis et al., 1991; Chen et al., 1995) . In this paper, we present the identi®cation Figure 6 Spi-1 binds to both Fli-1 and Ets-2 EBS elements. (a) MEL (lanes 1 ± 3) and K562 (lanes 4 ± 6) nuclear extracts were incubated with the oligonucleotide probe GATA/EBS. Competition experiments were carried out with excess GATA/EBS (G/E) (lanes 2 and 5) while supershift assay was performed with anti-Spi-1 (amino end) antibodies (lanes 3 and 6). The supershift observed in lane 6 is shown by a ®lled arrowhead. Bands A, B and C, and the non-speci®c band (NS) are indicated in the right end of the panel. (b) D1B nuclear extracts were incubated in the presence of either labeled GATA/EBS or a labeled oligonucleotide containing the same EBS element initially described by Klemsz et al. (1990) in the MHC class II gene. (c) K562 (lanes 1 ± 3) and D1B (lane 4 ± 7) nuclear extracts were added to the 32 P-labeled ETS-2PR oligonucleotide and supershift assays were then performed with anti-Spi-1 antibodies directed either against the amino end (Sn) (lane 2 and 5), the carboxyl end of the protein (Sc) (lane 6) or anti-ets-2 antibodies (E) (lanes 3 and 7) . The presumed Spi-1 band is indicated and the induced supershift is pointed out by a ®lled arrowhead of multiple factors binding to the conserved EBS and GATA elements of another member of the Ets family: Fli-1. Most notably, we observed that the GATA/EBS dual element near the Fli-1 CAP sites had an enhancer activity in HEL cells. Spi-1 and GATA-1 were both found to bind to this sequence and hence both factors could represent potential regulators of Fli-1 expression.
In the present study, we were ®rst interested in analysing the EBS elements present in the Fli-1 exon 1 and intron 1 regions since these elements were conserved between human and mouse (Barbeau et al., 1996) . Several factors were shown to bind to the EBS element found in the Fli-1 exon, while only one major factor was able to bind to the EBS element of intron 1. This latter factor (termed B'; see Figure 7 ) appeared Ets-related since the EBS site had to be intact for binding and also because it disappeared when competed with other EBS-containing oligonucleotides. The importance of the interaction of the Fli-1 EBS intronic element with its Ets-related factor for Fli-1 gene expression remains to be determined although functionally important EBS elements in intronic sequence have already been described (Nelsen et al., 1993) .
In Figure 7 , a schematic presentation of the various factors binding to the GATA/EBS dual element is shown. Three of these factors, which are apparently ubiquitous, remain to be identi®ed, but seem clearly dependent on an intact EBS core element; factor A, a high molecular weight factor which showed speci®city toward the Fli-1 exon 1 EBS element; factor B, showing preference to this element versus the EBS element of intron 1 and factor B' showing a weaker anity for this region. Several Ets-related factors are known to be ubiquitously expressed, like GABP-a, ER81 and ets-2 (Bhat et al., 1987; LaMarco et al., 1991; Brown and McKnight, 1992) . In our hands, no supershift could be seen upon treatment with anti-Ets-2 antibody using several dierent nuclear extracts. In addition, no supershift could be visualised after addition of anti-Fli-1 antibodies in EMSA analysis with either the EBSi or the GATA/EBS probes. This argues that the potential auto-regulatory loop of Fli-1 gene expression described in the transgenic Fli-1 mouse model by Zhang et al. (1995) would not be mediated via direct contact of the Fli-1 protein to the EBS elements described in this study. Experiments are presently underway to identify the factors A, B and B'.
Our transfection experiments in the HEL cells indicated that a human Fli-1 fragment harboring the GATA/EBS dual element increased SV40 promoterdependent transcription in an orientation-independent fashion and that the oligonucleotide GATA/EBS had the same activating potential. Furthermore, our results demonstrated that the enhancing eect of the GATA/ EBS oligonucleotide was proportional to the number of copies inserted upstream of the SV40 promoter and seemed dependent on an intact EBS element. These results suggested that the GATA/EBS element is typical of an enhancer element and that the factors most likely recognizing the EBS sequence are important in this enhancer eect. However, the GATA sequence might also be important since a certain level of induction was observed in the EBS-mutated pGL3promoter construct. In fact, the multitude of the presumed Ets-related factors binding to the EBS element of the Fli-1 exon 1 (see Figure 7 ) might suggest that other factors binding to adjacent elements might act cooperatively with the factors binding to the EBS element and be important for the activation potential of this Fli-1 region. In that sense, the identi®cation of the binding of the GATA-1 factor to this motif is of signi®cance, especially since certain genes have been shown to contain functionally cooperative GATA/EBS dual elements (Galson et al., 1993; Henkel and Brown, 1994) . However, our results do not suggest co-binding of the potential Ets-related factors and GATA-1 since only a single band could be supershifted with anti-Spi-1 and anti-GATA-1 antibodies even when high concentration of nuclear extracts was used (data not shown). Nonetheless, the identi®cation of a conserved GATA-1 binding site next to the mouse Fli-1 CAP sites (Barbeau et al., 1996) strongly supports a potential role of this element in Fli-1 expression. In addition, other GATA family members expressed in nonerythroid cell lines and in non-hematopoietic-related organs (Orkin, 1992) could equally be important in Fli-1 regulation in these cellular contexts through the GATA/EBS dual element.
The identi®cation of band C as Spi-1 did come as a surprise in this study. Spi-1 is a member of the ets gene family, and has been shown to be rearranged in SFFV- Figure 7 Summary of the bound complexes observed for the Fli-1 GATA/EBS exon 1 and EBS intron 1 regions. The two major CAP sites (Barbeau et al., 1996) are indicated by an arrow above the map. The EBS and GATA elements are represented in the context of the 5' end of the mouse Fli-1 locus. GATA-1 and Spi-1 are two identi®ed factors which, like the unidenti®ed factor A, exclusively bind to the GATA/EBS region. Factors B and B' both bind to the two EBS-containing regions, the weakest anity interaction being represented by an incomplete arrow induced erythroleukemias (Moreau-Gachelin et al., 1988; Goebl et al., 1990) . Its binding site is purinerich (Moreau-Gachelin, 1994) , and thus corresponds well to both Fli-1 and Ets-2 exon 1 EBS elements. A recent report has shown that the ets-related factor ERF could repress promoter activity via its binding to the Ets-2 EBS element (Sgouras et al., 1995) . However, this ets-related factor was shown to be ubiquitous and thus does not correspond to the previously described band H3 speci®c to the Ets-2 EBS element nor to band C in this report. Since it has been demonstrated that tumors from transgenic mice expressing Spi-1 were all found to express high levels of Fli-1 (Moreau-Gachelin, personal communication), Spi-1 might thus be considered a positive regulator of the expression of Fli-1. On the other hand, our model would then suggest that Fli-1 expression in T-cell lines (Watson et al., 1992; Bergeron et al., 1993; Hromas et al., 1993a; Klemsz et al., 1993) which have been often found not to express Spi-1 (Hromas et al., 1993b; Moreau-Gachelin, 1994 ) might be independent of the Spi-1 transcription factor. Experiments addressing these questions are presently underway.
A particular aspect of the binding of the Spi-1 factor to the Fli-1 exon 1 EBS element was the identi®ed low molecular weight bands seen in the myeloid cell lines (band Q). Low molecular weight signals obtained with the GATA/EBS were shown to be of low anity towards the binding site. Although this might represent a new complex with low anity towards GATA/EBS, we favor the hypothesis that degradation products of the Spi-1 protein are responsible for this complex. Such similar bands have been noticed with myeloid cell line extracts in the presence of Spi-1 binding sites derived from several other loci (Carvalho and Derse, 1993a; Feinman et al., 1994; Eichbaum et al., 1994) . Carvalho and Derse (1993b) have shown that a protease activity present mainly in immature myeloid cells can degrade Spi-1 giving rise to Spi-1-fragmented molecules which can still bind to DNA. Indeed, the low molecular weight bands in our study could be blocked by antibodies directed against the carboxyl terminal but not the amino terminal region of Spi-1, which is consistent with the fact that the Spi-1 DNA binding domain is present at its carboxyl extremity. Furthermore, the Spi-1-related low molecular weight signals observed in our study are less abundant in the WEHI-3B cell line compared to the more immature M1 and M-NFS cell lines. Unlike the full-length Spi-1 factor, we have observed that similar low molecular weight bands (which could be Spi-1-degraded molecules) seemed to be able to bind to the EBS element of intron 1. Deletion of domains outside the EBD region of Ets-1 and Elk-1 have been shown to aect their DNA binding speci®city Hahn and Wasylyk, 1994) , and it should thus be interesting to see whether these Spi-1 degradation products conclusively interact with a broader range of EBS elements.
Our results suggest that Fli-1 and Ets-2 could be both under the regulation of Spi-1. Since Spi-1 has been shown to be crucial in the generation of several hematopoietic cell types (Scott et al., 1994; MoreauGachelin et al., 1996) , the potential regulation of Fli-1 and Ets-2 expression by this ets member might be of some importance with respect to Spi-1 function in hematopoiesis. Further studies will thus be required to con®rm the potential role of Spi-1 in Fli-1 and Ets-2 gene regulation as well as for the potential implication of the GATA-1 factor in Fli-1 expression.
Materials and methods

Cell lines and origin
Mouse Ti6 (T-lymphoma, radio-induced), mouse M1 (myeloblast), mouse M-NFS-60 (myelogenous leukemia, G-CSF-dependent), mouse 32Dcl.3 (myeloid non-tumorigenic, IL3-dependent), mouse WEHI-3B (IL3 producing myelomonocyte) and human HL60 (promyelocyte) cell lines were grown in RPMI-1640 medium. The medium of M-NFS-60 and 32Dcl.3 cells was supplemented with 10% of WEHI-3B conditioned medium as a source of IL-3. Mouse NIH3T3 (®broblastic), hamster CHO (epithelial) and simian COS (epithelial) cell lines were cultured in DMEM medium. Finally, erythroleukemic cell lines MEL and CB7 (mouse, transformed by Friend MuLV), D1B (mouse, transformed by Friend MuLV complex), K562 (human, derived from a CML patient in blast crisis), and HEL (human) and the African green monkey kidney epithelial LTK 7 cell line were all cultured in MEM medium. All growth media were supplemented with 10% FCS and Penicillin/Streptomycin.
Preparation of nuclear extracts
Nuclear extracts were prepared from 10 9 cells for the cell lines Ti6, K562, D1B, CB7, M1, M-NFS and WEHI-3B following a previously described protocol (Wall et al., 1988) . Total micro-extracts (Aumont et al., 1993) were prepared for cell lines HL60, HEL, 32Dcl.3, COS, CHO, NIH3T3 and LTK 7 from 10 6 ± 10 7 cells.
Oligonucleotides
Oligonucleotides were synthesized on a Gene Assembler Plus apparatus (Pharmacia, Montreal, Canada) using the deoxyphosphoamidite method. They were mainly derived from the GATA/EBS dual element at position +126 of the Fli-1 promoter and at position +474 of Fli-1 intron 1 as deduced by the sequence of the mouse Fli-1 5' end (Barbeau et al., 1996 ; Figure 1 ). Sequence of the oligonucleotides is presented in Figure 1b .
Electrophoretic mobility shift assays
Fifty ng of sense strand oligonucleotide was 5' end labeled with g-23 P-ATP and T4 polynucleotide kinase and annealed with 200 ng of the complementary oligonucleotide. 0.8 ng of the labeled double-stranded oligonucleotide was added to 10 mg of nuclear extracts in 10 mM HEPES (pH 7.9) containing 1 mg/ml BSA, 200 mg/ml polydl/dC, 4% Glycerol, 1% Ficoll, 25 mM KCl, 1 mM DTT, 0.5 mM EDTA and 25 mM NaCl (total volume of 10 ml) and left for 20 min at room temperature. For competition assays, a 100-fold excess (80 ng) of cold double-stranded oligonucleotides was added in the mixture. For supershift assay, 1 ml of antibodies was added after the 20 min incubation and the sample was then transferred at +48C for 30 min. The antibodies tested for supershift assays were the polyclonal anti-Fli-1 antibody, a generous gift from Dr A Bernstein (Toronto, Canada), the polyclonal anti-Spi-1 antibody (amino terminus) kindly given by Dr F Moreau-Gachelin (Paris, France), and the polyclonal antibody anti-GATA-1, a kind gift from Dr L Wall (Montreal, Canada). The anti-Spi-1 (carboxyl terminus) and anti-Ets-2 antibodies (Palo Alto, CA, USA) were also tested. Samples were then run on a 4% acrylamide gel in 0.56TBE. Dried gels were exposed at 7808C on a Kodak X-OMAT ®lm. Autoradiograms were digitalized on a Personnal Densitometer SI (Molecular Dynamics) using the Image Quant 4.2 program.
RNA extraction and Northern analysis
Total RNA was extracted according to the guanidium/ isothiocyanate protocol and 20 mg of each sample were run on a formaldehyde/formamide agarose gel (Chomsinsky and Sacchi, 1987) . After transfer on nylon membrane, hybridization was carried out with random primer labeled probes overnight at 428C and the membranes were serially washed as described previously (Bergeron et al., 1993) . Membranes were exposed at 7808C on Kodak X-OMAT ®lm. Probes used are the mouse Fli-1 cDNA and the mouse Beta-actin cDNA. The mouse Fli-1 cDNA was kindly provided by Dr A Bernstein.
Plasmid constructions
The pGL3promoter plasmid (Promega) contains the SV40 promoter positioned downstream of a multiple cloning site followed by the luciferase reporter gene. The SH7 fragment (Barbeau et al., 1996) of the human Fli-1 gene was cut by SacI and HpaI and the 126 bp fragment containing the GATA/EBS element from exon 1 was then inserted in either orientation in the SmaI site of the pGL3promoter plasmid (pGL3promoter (SH7-S) and pGL3promoter (SH7-AS)). Phosphorylated oligonucleotides were similarly cloned in the SmaI site of the pGL3promoter construct and selected clones were then sequenced. The resulting plasmids pGL3promoter GATA/EBS(1), pGL3promoter GATA/EBS(2) and pGL3 promoter GATA/EBS(4) contain 1, 2 and 4 copies of the 5' GATA/EBS oligonucleotide (see Figure 1b) , respectively. The plasmid pGL3promoter GATA/EBS*(1) contains one copy of the oligonucleotide GATA/EBS* mutated in the EBS consensus sequence.
Transfection and measurement of luciferase and b-galactosidase activities
Pre-washed HEL cells (4.5610 6 cells) were incubated with 7.5 mg of lipofectine reagent (Gibco ± BRL) for 30 min at 378C in 150 ml OPTIMEM (Gibco ± BRL). In parallel, 5 mg of pGL3 promoter constructs along with 1 mg of pRSVb-gal were pre-incubated at room temperature for 15 min in 150 ml OPTIMEM, after which the DNA mixture was then added to the cell mixture. Following a 30 min incubation period at 378C, 13 ml of supplemented MEM medium was added and the cells were kept at 378C for 48 h. Cells were lysed in 1% Triton X-100 and luciferase activity was determined according to the manufacturer's protocol (Promega). Luciferase activity was read on a scintillation counter device and the values (CPM units) were normalized with respect to b-galactosidase activity measured as previously described (Hall et al., 1983) to account for variations in transfection eciency. Each experiment was performed in triplicate. The mean values were determined for each experiment and the activity of each construct was compared to that of the original pGL3promoter plasmid.
Note added in proof
During the evaluation process of this manuscript, another article by Starck et al. Molecular and Cellular Biology, 19, 121 ± 135, January 1999 , presented essentially the same results.
